1. Home
  2. STRW vs FBRX Comparison

STRW vs FBRX Comparison

Compare STRW & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strawberry Fields REIT Inc.

STRW

Strawberry Fields REIT Inc.

HOLD

Current Price

$13.18

Market Cap

151.1M

Sector

Real Estate

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$19.48

Market Cap

170.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRW
FBRX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
170.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STRW
FBRX
Price
$13.18
$19.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$12.72
$67.00
AVG Volume (30 Days)
33.5K
110.4K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
4.84%
N/A
EPS Growth
19.41
N/A
EPS
0.61
N/A
Revenue
$145,392,000.00
N/A
Revenue This Year
$35.42
N/A
Revenue Next Year
$7.19
N/A
P/E Ratio
$21.78
N/A
Revenue Growth
29.76
N/A
52 Week Low
$8.70
$4.90
52 Week High
$13.77
$28.68

Technical Indicators

Market Signals
Indicator
STRW
FBRX
Relative Strength Index (RSI) 71.15 65.81
Support Level $12.30 $17.33
Resistance Level $13.77 $19.22
Average True Range (ATR) 0.46 2.21
MACD 0.14 0.16
Stochastic Oscillator 73.97 77.71

Price Performance

Historical Comparison
STRW
FBRX

About STRW Strawberry Fields REIT Inc.

Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Share on Social Networks: